Abbott Laboratories
ABT
$109.61
$0.990.91%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 12.80% | -2.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.80% | -2.57% | |||
| Cost of Revenue | 8.90% | -0.47% | |||
| Gross Profit | 15.84% | -4.16% | |||
| SG&A Expenses | 7.96% | 22.34% | |||
| Depreciation & Amortization | 55.92% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.19% | 7.55% | |||
| Operating Income | 23.14% | -39.28% | |||
| Income Before Tax | 5.18% | -38.55% | |||
| Income Tax Expenses | 60.22% | -36.08% | |||
| Earnings from Continuing Operations | -13.83% | -39.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.83% | -39.36% | |||
| EBIT | 23.14% | -39.28% | |||
| EBITDA | 26.22% | -29.43% | |||
| EPS Basic | -13.74% | -38.37% | |||
| Normalized Basic EPS | 5.31% | -40.34% | |||
| EPS Diluted | -13.11% | -39.18% | |||
| Normalized Diluted EPS | 5.42% | -40.49% | |||
| Average Basic Shares Outstanding | -0.12% | -0.26% | |||
| Average Diluted Shares Outstanding | -0.23% | 0.00% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.16% | 0.76% | |||